Algernon Pharmaceuticals (AGNPF)
OTHER OTC:AGNPF

Algernon Pharmaceuticals (AGNPF) Financial Statements

72 Followers

Algernon Pharmaceuticals Financial Overview

Algernon Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-0.258; its P/E ratio is -0.35; Algernon Pharmaceuticals is scheduled to report earnings on July 26, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Feb 24Nov 23Aug 23May 23Feb 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBITC$ -1.00MC$ -521.55KC$ -2.53MC$ -1.13MC$ -1.25M
EBITDAC$ -996.26KC$ -514.13KC$ -2.51MC$ -1.11MC$ -1.23M
Net Income Common StockholdersC$ -1.00MC$ -521.55KC$ -2.53MC$ -1.13MC$ -1.25M
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsC$ 76.28KC$ 74.17KC$ 125.08KC$ 434.23KC$ 220.59K
Total AssetsC$ 3.95MC$ 3.95MC$ 4.19MC$ 6.14MC$ 6.03M
Total DebtC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Net DebtC$ -76.28KC$ -74.17KC$ -125.08KC$ -434.23KC$ -220.59K
Total LiabilitiesC$ 3.52MC$ 2.94MC$ 2.72MC$ 2.41MC$ 2.45M
Stockholders EquityC$ 437.32KC$ 1.01MC$ 1.47MC$ 3.72MC$ 3.59M
Cash Flow-
Free Cash FlowC$ -262.17KC$ -52.24KC$ -578.29KC$ -2.03MC$ -449.39K
Operating Cash FlowC$ -239.04KC$ -52.24KC$ -572.71KC$ -1.98MC$ -440.22K
Investing Cash FlowC$ -23.12K-C$ -5.58KC$ -53.92KC$ -9.17K
Financing Cash FlowC$ 265.57K-C$ 269.17KC$ 1.06MC$ -17.18K
Currency in CAD

Algernon Pharmaceuticals Earnings and Revenue History

Algernon Pharmaceuticals Debt to Assets

Algernon Pharmaceuticals Cash Flow

Algernon Pharmaceuticals Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis